mountsinaihospital.com
This role involves conducting research on myeloid malignancies using human pluripotent stem cells, including cell culture, genetic modification, and mouse transplantation experiments. The position also contributes to COVID-19 pandemic research by generating patient-derived iPSC models to study genetic predispositions to severe disease and testing viral entry in various cell types.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for mountsinaihospital.com.
mountsinaihospital.com didn’t post a salary, so this is our estimate from similar listings.
39% below the average for this role